Picture of Level Bio AB (publ) logo

LEVBIO Level Bio AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Level Bio AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSPRESSARSPRESS
Standards:
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.525.21-2.41-9.69-8.19
Depreciation
Non-Cash Items0.5770.4920.9021.882.29
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.468-5.342.20.1771.41
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1.841.632.87-5.45-4.49
Capital Expenditures-0.288-0.0430
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.3-4.34-0.30.7710
Acquisition of Business
Sale of Fixed Assets
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities0.3-4.34-0.5880.7280
Financing Cash Flow Items-0.6450-0.116
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1.137.16-0.30.5071.94
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.014.441.98-4.21-2.55